Your browser doesn't support javascript.
loading
Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Suazo-Zepeda, E; Bokern, M; Vinke, P C; Hiltermann, T J N; de Bock, G H; Sidorenkov, G.
Afiliação
  • Suazo-Zepeda E; Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Zusterhuis, Hanzeplein 1, Groningen, The Netherlands.
  • Bokern M; Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Zusterhuis, Hanzeplein 1, Groningen, The Netherlands.
  • Vinke PC; Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Zusterhuis, Hanzeplein 1, Groningen, The Netherlands.
  • Hiltermann TJN; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • de Bock GH; Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Zusterhuis, Hanzeplein 1, Groningen, The Netherlands.
  • Sidorenkov G; Department of Epidemiology, Graduate School of Medical Sciences, University of Groningen, Zusterhuis, Hanzeplein 1, Groningen, The Netherlands. g.sidorenkov@umcg.nl.
Cancer Immunol Immunother ; 70(11): 3069-3080, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34195862
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda